The aim of the study is to check whether dexmedetomidine has neuroprotective properties in brain injury patients.
The enrolled 60 patients will be divided into two groups; Group 1(n=30):
are the patients who will receive dexmedetomidine. Group 2 (n=30): are the patients who represent the control group.